Alivus Life Sciences Financial Results
- Market cap
- ₹16,846 crore
- P/E
- 27.9
- P/B
- 5.06
- ROE
- 18.4%
- Dividend yield
- 0.36%
For the year ended Mar 2022, Alivus Life Sciences reported revenue of ₹2,123 crore and net profit of ₹419 crore, against ₹2,048 crore and ₹467 crore a year earlier.
Alivus Life Sciences annual profit and loss
Financial years, newest first. TTM = trailing twelve months.
| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 2,123 | 2,048 | 2,185 | 2,340 | 2,504 | 2,543 |
| Expenses | 1,507 | 1,405 | 1,509 | 1,655 | 1,706 | 1,706 |
| Operating profit | 616 | 643 | 676 | 684 | 798 | 837 |
| Operating margin % | 29% | 31% | 31% | 29% | 32% | 33% |
| Other income | 15 | 28 | 11 | 33 | 34 | 48 |
| Interest | 28 | 1 | 2 | 2 | 5 | 5 |
| Depreciation | 38 | 42 | 53 | 61 | 75 | 79 |
| Profit before tax | 565 | 629 | 631 | 654 | 751 | 801 |
| Tax % | 26% | 26% | 25% | 26% | 25% | 25% |
| Net profit | 419 | 467 | 471 | 486 | 564 | 603 |
| EPS (₹) | 34.17 | 38.11 | 38.43 | 39.63 | 45.99 | 49.13 |
| Dividend payout % | — | — | — | — | — | — |
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
Alivus Life Sciences financial results — frequently asked questions
What is Alivus Life Sciences' annual revenue and net profit?
For the financial year ended Mar 2022, Alivus Life Sciences' revenue was ₹2,123 crore and net profit ₹419 crore; net profit fell 10.28% from ₹467 crore in Mar 2023.
How fast has Alivus Life Sciences grown over three years?
From Mar 2025 to Mar 2022, Alivus Life Sciences' revenue grew at a compound annual rate of -3.2% and net profit at -4.8%. Past growth does not indicate future results.
What is the EPS of Alivus Life Sciences?
Annual EPS for Mar 2022 was ₹34.17.
Are these figures consolidated or standalone?
They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Same Data For Peers
Trade Alivus Life Sciences With ATS
Track ALIVUS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.